Related Experiment Video

Updated: Feb 5, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth

Robert Berahovich1, Hua Zhou2, Shirley Xu3

  • 1ProMab Biotechnologies, 2600 Hilltop Drive, Richmond, CA 94806, USA. robert.berahovich@promab.com.

Cancers
|September 14, 2018
PubMed

Insights

A new antibody, clone 4C8A, enables the development of novel B cell maturation antigen (BCMA)-targeted CAR-T cells. These engineered cells show significant efficacy against multiple myeloma in preclinical models, warranting further clinical investigation.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • B cell maturation antigen (BCMA) is a key target for multiple myeloma therapies.
  • Chimeric antigen receptor (CAR)-T cell therapy offers a promising approach for treating multiple myeloma.

Purpose of the Study:

  • To develop a novel BCMA-targeting CAR-T cell therapy.
  • To evaluate the efficacy of a new BCMA-specific monoclonal antibody, clone 4C8A, in CAR-T cell construction.

Main Methods:

  • Generation of a novel BCMA monoclonal antibody (clone 4C8A).
  • Construction and characterization of BCMA-specific CAR-T cells using the 4C8A single-chain variable fragment (scFv).
  • In vitro assessment of CAR-T cell cytotoxicity and cytokine secretion (IFN-γ).
  • In vivo evaluation in mouse models of multiple myeloma (subcutaneous tumor model).

Main Results:

  • The 4C8A antibody demonstrated strong and selective binding to human BCMA.
  • BCMA CAR-T cells exhibited potent in vitro cytotoxicity against multiple myeloma cell lines and secreted high levels of IFN-γ.
  • In vivo studies showed significant inhibition of tumor formation and regression of established tumors.
  • Humanized BCMA-CAR-T cells also demonstrated efficacy in vivo.

Conclusions:

  • Novel CAR-T cells engineered with the BCMA 4C8A scFv are effective against multiple myeloma.
  • These findings support the clinical development of BCMA-targeted CAR-T cell therapy using the 4C8A antibody.
Keywords:
CAR-T cellscancercell therapychimeric antigen receptorimmunotherapymultiple myelomatumor antigenxenograft

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.5K
Generation of Monoclonal Antibodies Against Natural Products12:15

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

11.6K

Related Concept Videos

Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
5.1K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.1K
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.6K
Block Diagram Reduction01:22

Block Diagram Reduction

The process of deriving the transfer function of a control system often involves reducing its block diagram to a single block. This simplification can be achieved through a series of strategic operations, including relocating branch points and comparators. These operations preserve the overall function of the system while allowing for easier manipulation and combination of blocks.
The first step in this process is the identification and relocation of a branch point. A branch point, where a...
567
Meristems and Plant Growth02:36

Meristems and Plant Growth

Plants grow throughout their lives; this is called indeterminate growth, and it distinguishes plants from most animals. Although certain parts of plants stop growing (e.g., leaves and flowers), others grow continuously—like roots and stems.
49.6K
What are Cells?01:07

What are Cells?

Cells are the smallest and basic units of life, whether it is a single cell that forms the entire organism, e.g., in a bacterium or trillions of them, e.g., in humans. No matter what organism a cell is a part of, they share specific characteristics.
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
201.2K